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Improvement of muscle peak power and oxidative capacity are generally presumed to be mutually exclusive. However, this may
not be valid by using fibre type-specific recruitment. Since rat medial gastrocnemius muscle (GM) is composed of high and low
oxidative compartments which are recruited task specifically, we hypothesised that the adaptive responses to peak power training
were unaffected by additional endurance training. Thirty rats were subjected to either no training (control), peak power training
(PT), or both peak power and endurance training (PET), which was performed on a treadmill 5 days per week for 6 weeks.Maximal
running velocity increased 13.5% throughout the training and was similar in both training groups. Only after PT, GM maximal
force was 10% higher than that of the control group. In the low oxidative compartment, mRNA levels of myostatin and MuRF-1
were higher after PT as compared to those of control and PET groups, respectively. Phospho-S6 ribosomal protein levels remained
unchanged, suggesting that the elevated myostatin levels after PT did not inhibit mTOR signalling. In conclusion, even by using
task-specific recruitment of the compartmentalized rat GM, additional endurance training interfered with the adaptive response
of peak power training and attenuated the increase in maximal force after power training.
1. Introduction
Optimal physical performance, during for instance cycling
and rowing, requires both high peak power and maximal
oxidative capacity of skeletal muscles. Hickson (1980) was
the first to study the effects of concurrent strength and
endurance training (further referred to as concurrent train-
ing) aiming at increasing both maximal force and endurance
[1]. During concurrent training, the gain in maximal mus-
cle force (𝐹𝐹max) was shown to be attenuated, whereas no
negative effect on the maximal oxygen uptake (𝑉𝑉O2 max)
was observed [1]. Since the study of Hickson (1980), the
effects of concurrent training on 𝐹𝐹max have been intensively
studied in humans, supporting as well as contradicting the
findings of Hickson [1–7]. Recently, several interactions
in the molecular regulation of the synthesis of contrac-
tile proteins and biosynthesis of mitochondria have been
uncovered, suggesting that muscle fibres seem to be lim-
ited in increasing size (and therefore maximal force) and
oxidative capacity simultaneously [8–11]. Although the two
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training modalities interfere with one another at the cellular
level, the entire muscle may be able to adapt to both types of
training without a negative effect on 𝐹𝐹max in response to the
additional endurance training [5, 7]. However, the underlying
mechanisms are still unclear and the question remains as to
how these two training modalities can best be combined to
improve peak power and endurance simultaneously.
A possible mechanism may be the use of specific recruit-
ment of muscle fibres during different tasks. For instance,
motor units consisting of slow high oxidative muscle fibres
may be recruited during endurance training and increase
the oxidative capacity, whereas motor units consisting of
fast and large muscle fibres may primarily be used dur-
ing peak power training and increase in size and there-
fore contribute to the increase in 𝐹𝐹max. Such task-specific
recruitment and adaptation of motor units may be studied
in rat medial gastrocnemius muscle (GM), as this muscle is
composed of high and low oxidative compartments which
are recruited tasks specifically [12]. During low intensity
activities, the high oxidative compartment is active, whereas
only during high intensity activities, such as sprinting, also
the low oxidative compartment is recruited [12, 13]. The aim
of the current study was to investigate whether by using
task-specific recruitment of high and low oxidative muscle
fibres the effects of peak power training on this muscle
was attenuated when combined with endurance training. We
hypothesised that in compartmentalized rat GM, increases
in maximal muscle force and muscle fibre size were not
attenuated by additional endurance training compared to
peak power training alone. In addition, in the low oxidative
compartment, after both peak power training and concurrent
training, we expected a similar increase in mRNA expression
levels of genes inducing hypertrophy as well as reduction in
mRNA levels of genes stimulating protein degradation.
2. Materials and Methods
2.1. Animal Care and Experimental Design. The experiment
was approved by the Animal Experiments Committee of the
VU University Amsterdam and animals were kept according
to the guidelines of animal care. The study was conducted
with 30 female Wistar rats at the age of 10 weeks; food and
water were provided ad libitum. The rats were subjected to
either peak power training (PT; 𝑛𝑛 𝑛 𝑛𝑛), combined peak
power training with additional endurance training (PET; 𝑛𝑛 𝑛𝑛𝑛), or remained untrained (control; 𝑛𝑛 𝑛 𝑛𝑛). In order to
train the rats during their active period of the day, the
12-h light: 12-h dark cycle was reversed. During a three
week acclimatization period, rats of the training groups were
familiarizedwith running and/or sprinting on amotor driven
treadmill. Following this, the 6-week training period started,
during which the rats of the PT and PET group trained 5 days
per week. For studying effects on bone mineralization (not
reported here) 9 and 2 days before sacrificing, a very small
dose of tetracycline (25mg/kg) was injected intraperitoneally
(i.p.). To standardize for the gene expression and to exclude
the acute effects of one training bout, the last training was
performed approximately 22 hours before sacrificing (peak
power training for the PT group and endurance training for
the PET group).
2.2. Training Protocols. Peak power training consisted of 10
sprints of 15 seconds at near maximal velocity with 3 minutes
of rest between the sprints. During these sprints, the rats were
in gallop resembling explosive repetitive jumps of the hind
limbs. Once in gallop, the speedwas increased up to a velocity
at which the rat could not stay in the front of the treadmill.The
slope of the treadmill was progressively increased throughout
the 6 weeks of training, starting at 10% and rising to 40%.
To fulfil the criteria of a successful training, the rats had
to attain near maximal velocities while they were in gallop.
When such velocities (due to poor coordination or lack of
motivation) were not attained, the training was not counted
as successfully completed. For inclusion in this study, every
week at least four training sessions had to be successfully
completed. All rats (PT and the PET groups) were subjected
to the peak power training in themorning to ensure that they
had recovered from the last training session the day before.
The PET group performed additional endurance training on
the same day in the afternoon (8 hours later). The endurance
training consisted of training sessions in which the duration
was increased progressively from 10minutes up to 45minutes
after 6 weeks and the inclination and velocity were increased
from 0% to 10% and from 16m/min to 26m/min (trotting),
respectively. Rats that did not sustain the training duration at
the given inclination and speed during at least three training
sessions, were excluded from this study.
2.3. Functional Performance Test. Functional performance
was defined as themaximal running velocity attained at a 40%
inclination. The PT and PET groups performed a maximal
running velocity test at 40% inclination consisting of several
sprint of 15 seconds every two weeks. The velocity started
at 36m/min and was increased with each sprint by steps of
approximately 5m/min up to their maximal velocity (with 3
minutes rest between the sprints). Since performingmaximal
sprints was a coordinative difficult task, requiring lots of
practice, the control group did not perform the maximal
running velocity tests to prevent measuring only their skills,
which would result in an underestimation of their real
maximal running velocity. For the same reason, the first
functional performance test was performed after 2 weeks.
2.4. Experimental Protocol. To measure the contractile mus-
cle force characteristics in situ, which took place one day after
the last training, rats were anesthetized by an initial dose
of 1.2mL/100 g body weight urethane (i.p.) [14]. Within the
following hour, they received 2-3 injections (i.p.) of 0.5mL
urethane (until nociceptive reflexes disappeared). The body
temperature of the rat was maintained at 37∘C. The right
medial gastrocnemius muscle (GM), including the Achilles
tendon with a piece of the calcaneus, was separated from
the surrounding tissue leaving the proximal origin, the blood
supply, and nerves intact. The sciatic nerve was exposed
carefully and severed approximately 2 cm proximal of the
GM. Nerve branches from the sciatic nerve, innervating
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other muscles than the GM, were also severed. The right
hind limb was fixed using a metal clamp at the femur, the
Achilles tendon was attached to a force transducer, and the
nerve was placed over electrodes. During the experiment, the
muscle and its surrounding were kept moist at physiological
temperature (34-35∘C).The experimental setupwas similar as
described previously [12].The contractile force characteristics
were measured using nerve stimulation (1.5mA) at optimum
length (𝐿𝐿𝑜𝑜), defined as the length at which the tetanic
contraction force (150Hz, 150ms) was maximal (𝐹𝐹max). Force
and length signals were sampled at 10 kHz.
Force-velocity (F-V) relationships were determined by
a series of maximally stimulated concentric contractions
(400Hz) at different constant velocities (10, 20, 30, 50, 75,
100, 125, 150, 200, 250mm/s). After stretching the muscle
passively 1–1.5mm above 𝐿𝐿𝑜𝑜, the contraction started with an
isometric phase during which active force reached a level
which could be maintained during the shortening phase [15].
The F-V data were fitted using Hill equations and the least-
squares method. Curvature (a/𝐹𝐹0) and maximum shortening
velocity (𝑉𝑉max) were determined. The power-velocity curve
was obtained by multiplying, for each velocity, the velocity
by its force. Maximal peak power (𝑃𝑃max) and its optimum
shortening velocity (i.e., V at 𝑃𝑃max, 𝑉𝑉opt) were determined
by the fitted Hill curve. After force measurements, the GM
was excised, weighed, stretched to 𝐿𝐿𝑜𝑜, and rapidly frozen and
stored in liquid nitrogen until further analysis. Specific force
was estimated by dividing 𝐹𝐹max by the GMmass (N/g).
2.5. Histochemistry. As the high and low oxidative compart-
ments of the GM are recruited task specifically [13], the fibre
cross-sectional area (FCSA) in the two compartments were
assessed separately. Cross-sections (10 𝜇𝜇m thick) were cut
from the middle of the GM, which contained muscle fibres
from both the high and low oxidative regions. The cross-
sections were mounted on Vectabond (Vector Laboratories,
Burlingame, CA, USA) coated slides and stored in −80∘C
until further analysis.
To determine the CSA of the different fibre types in each
compartment, images were captured with a 20x objective
using theDMRBmicroscope (Leica,Wetzlar, Germany) from
stained cross-sections and matched with the myofibrillar
adenosinetriphosphatase (ATPase) staining to differentiate
between the four fibre types (type I, type IIA, type IIX, and
type IIB) [16–18]. Mean FCSA was determined from the
FCSA of at least 20 fibres per type per compartment from
these images which were calibrated using a slide micrometer
and the set scale option in ImageJ 1.44p (National Institute
of Mental Health, MD, USA), taking the pixel-to-aspect ratio
into account.
2.6. RNA Isolation and Quantitative Polymerase Chain Reac-
tion (qPCR). For extraction of RNA from the high oxidative
and low oxidative compartments of GM, sections were cut
from the proximal and distal end of the GM, respectively.
To illustrate the distribution of high and low oxidative fibres
in the proximal and distal region of GM, a typical example
of cross-sections stained for succinate dehydrogenase (SDH)
activity is shown in Figures 3(a) and 3(b). To isolate RNA
from the muscle tissue, RiboPure kit (Applied Biosystem,
Foster City, USA) was used according to the manufacturer’s
protocol. RNA concentration and purity (260/280 nm mean
ratio: 2.03; range: 1.89–2.13) were measured using spectro-
scopy (Nanodrop Technologies, Wilmington, DE, USA).
Using the high capacity RNA-to-cDNA kit (Applied Biosys-
tems, Foster City, USA) containing random primers in a
20𝜇𝜇L total reaction volume, 500 ng of total RNA per muscle
compartment was reverse transcribed. Tubes were heated at
25∘C for 5min, followed by 42∘C for 20min. Finally, to stop
the reaction, the tubes were heated at 85∘C for 5min and
stored at −80∘C until used in the quantitative PCR reaction
(method described previously) [19]. Expression levels of
mRNAwere assessed for insulin-like growth factor 1Ea (IGF-
1Ea), myostatin, 𝛼𝛼-skeletal actin, muscle ring finger 1 (MuRF-
1) and muscle atrophy F-box (MAFbx; also known as artogin
1) (see Table 1 for primer sequences). Melting curve analysis
showed specific amplification and amplification efficiencies
of the primers used in this study ranged from 91.3–102%.
Expression levels were expressed relative to 18S rRNA using
the 2−ΔCt method. 18S rRNA was analysed in triplicate and
the other samples in duplicate.
2.7. Protein Isolation and Western Blotting. For protein ex-
traction of the high and low oxidative compartments of GM,
50 sections (20𝜇𝜇mthick) were cut from the proximal and dis-
tal regions, respectively. Subsequently, the tissue was homo-
genized in ice-cold radioimmunoprecipitation assay (RIPA)
buffer (Sigma-Aldrich, St. Louise MO, USA) containing
protease and phosphatase inhibitor cocktail tablets (Roche,
Mannheim, Germany). After centrifuging for 10min at
12000 rpm at 4∘C, the supernatant was stored at −80∘C.
Protein concentrations were determined using the bicincho-
ninic acid protein assay (Pierce, Rockford IL, USA). After
denaturing the samples in SDS-PAGE sample buffer for
5min at 90∘C, 5 𝜇𝜇g of protein were subjected to SDS-
PAGE and transferred to a nitrocellulose membrane (GE
Healthcare, Little Chalfont, UK). Following this, the mem-
brane was blocked with 5% ECL Advance Blocking Agent
(Amersham, GE Healthcare, Little Chalfont, UK) in TBS
with 0.01% Tween 20, incubated overnight at 4∘C with
primary antibody against phospho-S6Ser235/236 ribosomal
protein (1 : 1000; Cell Signaling Technology) and actin
(1 : 1000; Cell Signaling Technology), and followed by a
specific horseradish peroxidase-conjugated polyclonal goat
antirabbit secondary antibody (1 : 2000; DakoCytomation).
Enhanced chemiluminescence kit (ECL Advance, Amer-
sham, GEHealthcare, Little Chalfont, UK) was used to detect
the antibody. Phospho-S6 data were normalized to actin.
2.8. Data Analysis. For comparison of muscle mass, maximal
force, and FCSA between the different groups, these param-
eter values were normalized to the ratio between individual
body mass and overall mean body mass at the end of the
experiment. This accounted for variations in growth rate of
the animals.
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Table 1: Sequences of the specific primers used in the quantitative PCR analyses.
Target mRNA PCR primer sequence 5
󸀠󸀠–3󸀠󸀠
Forward Reverse
18S rRNA CGAACGTCTGCCCTATCAACTT ACCCGTGGTCACCATGGTA
IGF-1Ea AAGCCTACAAAGTCAGCTCG TCAAGTGTACTTCCTTCTGAGTC
myostatin GGTCCCGGAGAGACTTTGG CGACAGCACCGCGATTC𝛼𝛼-skeletal actin CGACATCGACATCAGGAAGGA GGTAGTGCCCCCTGACATGA
MuRF-1 TGCCCCCTTACAAAGCATCTT CAGCATGGAGATGCAATTGC
MAFbx TGAAGACCGGCTACTGTGGAA CGGATCTGCCGCTCTGA
PCR: polymerase chain reaction, IGF-1Ea: insulin-like growth factor 1Ea, MuRF-1: muscle ring finger 1, MAFbx: muscle atrophy F-box.
2.9. Statistical Analysis. Data was analysed using SPSS ver-
sion 18.0 (SPSS Inc., Chicago, USA). When the data was
normally distributed, differences between groups in maximal
running velocity, GM force as function of shortening velocity,
and GM power-velocity curve were tested using a mixed
design repeated measures ANOVA. One-way ANOVAs were
performed to assess the differences in maximal force, FCSA,
and gene and protein expression levels between the three
groups. Bonferroni post hoc analysis was performed when
a significant main effect of group was found. When data
was not normally distributed according to the Shapiro-Wilk
test (IGF-1Ea, MuRF-1 and MAFbx mRNA, and phospho-
S6 levels in both compartments), Kruskal-Wallis Test was
performed to test for differences between the three groups.
In case of significant main effects, Mann-Whitney 𝑈𝑈 Test
was used to compare the different groups. The 𝑃𝑃 value was
adjusted using the Bonferroni method. The results are pre-
sented inmean ± SE. Significance was considered at𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃.
3. Results and Discussion
In total, 20 rats were trained. However, three rats of the PT
group did not complete enough training sessions successfully
and were therefore excluded. During force measurements,
GM of three rats (two rats of the PET and one of the control
group) were damaged due to technical problems, resulting
in 3 additional exclusions. Therefore, the ultimate number of
rats used for all analyses were for control 𝑛𝑛 𝑛 𝑛, for PT 𝑛𝑛 𝑛 𝑛,
and for PET 𝑛𝑛 𝑛 𝑛. The initial and final body masses were not
significantly different between the three groups (Table 2).
3.1. Effects of Training on Functional Performance, Contractile
Force Characteristics and Hypertrophy of Rat GM. Themaxi-
mal running velocity increased 13.5% (𝑃𝑃 𝑛 𝑃𝑃𝑃𝑃𝑃) throughout
the last 4 weeks of training in both groups (Figure 1(a)),
and was not significantly different between the PT and PET
group. After PT, 𝐹𝐹max was 10% higher compared to that of
controls (𝑃𝑃 𝑛 𝑃𝑃𝑃𝑃𝑃), whereas after PET, mean 𝐹𝐹max was
neither significantly different from controls nor PT, indicat-
ing that the additional endurance training attenuated the
increase in 𝐹𝐹max (Figure 1(b)). For the PT group, also forces
as a function of velocity were significantly higher (𝑃𝑃 = 0.040)
than those of controls (Figure 1(c)). Similar to the results
for 𝐹𝐹max, for the PET group, forces as a function of velocity
did neither differ from those of controls nor from those of
Table 2: Initial and final body and medial gastrocnemius muscle
(GM) mass.
Group Body mass (g) ± SE Muscle mass (g) ± SE
Initial body mass Final body mass Final GMmass
Control
(𝑛𝑛 𝑛 𝑛) 208.1 (±4.1) 255.2 (±7.4) 0.691 (±0.013)
PT
(𝑛𝑛 𝑛 𝑛) 201.7 (±3.5) 250.1 (±3.7) 0.748 (±0.021)
PET
(𝑛𝑛 𝑛8) 211.0 (±3.6) 254.5 (±2.3) 0.717 (±0.014)
PT: peak power training; PET: combined peak power training and additional
endurance training. Values are mean ± SE.
PT group. The power-velocity curves were not significantly
different between the three groups (𝑃𝑃 𝑛 𝑃𝑃𝑃𝑃𝑃). A tendency
(𝑃𝑃 𝑛 𝑃𝑃𝑃𝑛𝑃) was found towards a difference in 𝑃𝑃max between
the three groups, whereby 𝑃𝑃max of the PT group was 13.9%
higher (3𝑛6𝑃𝑃 ± 𝑃𝑃𝑃𝑛mWatt) than that of controls (33𝑛𝑃𝑃 ±𝑃𝑃𝑃𝑃mWatt) and 14.7% higher (336𝑃6±𝑃𝑛𝑃𝑃mWatt) compared
to that of the PET group. While 𝐹𝐹max of the PET group
could not be shown to be higher after training, maximal run-
ning velocity increased throughout the training.The increase
in running performance may be caused by improved recruit-
ment and coordination of agonists and antagonists as shown
after resistance training [20–23], or 𝐹𝐹max of synergistic mus-
cles may have increased after training, which may also have
contributed to the better running performance.
The higher 𝐹𝐹max after PT (isometrically as well as as a
function of velocity) may be explained by either changes
in cross-bridge kinetics and/or Ca2+-sensitivity, hypertrophy,
or increased specific force. Since no significant differences
between groups were observed in𝑉𝑉max and a/𝐹𝐹0, representing
the force-velocity curvature, training was unlikely to induce
changes in the number of sarcomeres in series, cross-bridge
kinetics, and/or Ca2+-sensitivity.
As the GM is a compartmentalized muscle, of which the
high oxidative compartment of controls consisted of 23𝑃𝑛 ±𝑃𝑃𝑃% type I, 22𝑃𝑃 ± 𝑃𝑃𝑛% type IIA, 3𝑃𝑃𝑛 ± 2𝑃2% type IIX, and𝑃𝑛𝑃𝑃±𝑃𝑃2% type IIB fibres and the low oxidative compartment
for 𝑃𝑛𝑃𝑛 ± 3𝑃𝑃% of type IIX and 𝑛2𝑃2 ± 3𝑃𝑃% of type IIB fibres
(data not shown), we investigated whether fibre type-specific
changes in CSA may explain the attenuated increase in 𝐹𝐹max
after PET. In both compartments, training did not affect
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Figure 1: Effects of training on running performance and GM force characteristics of the rats. Effects of peak power training alone (PT)
and peak power training in combination with endurance training (PET) on (a) maximum running velocity, (b) maximal force (𝐹𝐹max), and (c)
force-velocity and power-velocity curves of the ratmedial gastrocnemiusmuscle. Forces as a function of contraction velocitywere significantly
higher after PT compared to those of controls. Symbols (control: white diamond, PT: black triangle, PET: black circle) on the force velocity
curve indicate the isometric 𝐹𝐹max and symbols on the power curve indicate maximal peak power at optimum shortening velocity. All values
are mean ± SE. ∗= significant difference between the groups (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃); §= significantly different from control (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃).
the FCSA of any fibre type (Figure 2). However, the tendency
(𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃) observed towards an 8% higher GM mass after
PT compared to controls (Table 2) and unchanged specific
force after training (control 18𝑃9𝑃 ± 𝑃𝑃4𝑃N/g; PT 19𝑃32 ±𝑃𝑃𝑃𝑃N/g; PET 19𝑃21 ± 𝑃𝑃29N/g) suggests that the increase in𝐹𝐹max seen after PT may be due to muscle hypertrophy.
3.2. Effects of Training on Genes Involved in the Regulation
of Muscle Hypertrophy and Atrophy of GM. To obtain an
indication of the regulatory mechanisms underlying the
training-induced adaptations and the possible interaction,
we investigated steady-state mRNA expression levels of two
key growth factors, insulin-like growth factor- (IGF-) 1Ea
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Figure 2: Effects of training on muscle fibre size. Peak power training alone (PT) and peak power training in combination with endurance
training (PET) did not change the fibre cross-sectional area (FCSA) in the high oxidative (a) and low oxidative (b) compartments of the rat
medial gastrocnemius muscle. All values are mean ± SE. ∗= significant difference between the groups (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃).
and myostatin, and their downstream targets involved in
the regulation of muscle size and maximal force. IGF-1 may
increase the rate of mRNA translation by activating the
phosphoinositide 3-kinase (PI3 K)/Akt/mammalian target of
rapamycin (mTOR) signalling pathway and reduce the rate of
protein degradation via its inhibitory effect on the expression
of themuscle specific E3 ubiquitin ligases, muscle ring finger-
(MuRF-) 1, and muscle atrophy F-box (MAFbx) [24]. In
contrast, myostatin has opposite effects and is considered
a negative regulator of muscle growth [25–27] by reducing
Akt/mTOR signalling [28, 29] and stimulating expression
of MAFbx and MuRF-1 [27]. To assess the net effects of
changes in IGF-1 and myostatin expression on Akt/mTOR
signalling and protein degradation, we quantified phospho-
S6 protein levels andmRNA levels of𝛼𝛼-skeletal actin,MuRF-1
and MAFbx, respectively.
Total RNA and 18S RNA. In controls, total RNA content and
18S rRNA (2Ct) per ng total RNA were not different between
the high and low oxidative compartments. In both compart-
ments, training did not affect these parameters. Therefore,
mRNA expression levels of the different target genes were
expressed relative to 18S and considered as estimates of their
mRNA concentrations.
Effects of Training on High Oxidative Compartment. After
6 weeks of training, PT resulted in lower IGF-1Ea mRNA
levels (Figure 3(c); 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃) and higher myostatin and
MuRF-1 mRNA levels compared to PET (Figures 3(d) and
3(f); 𝑃𝑃 𝑃 𝑃𝑃𝑃2𝑃 and 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃, resp.). No significant differ-
ences were observed in mRNA levels of 𝛼𝛼-skeletal actin
and MAFbx and protein levels of phospho-S6 between the
three groups (Figures 3(e), 3(g), and 4). Thus, additional
endurance training on top of peak power training prevented
the reduction of the IGF-1Ea mRNA expression and increase
of myostatin mRNA and therefore prevented an increased
expression of the E3 ubiquitin ligase MuRF-1. Since PT
increased 𝐹𝐹max, an anabolic status of the muscle was expected
with higher IGF-1Ea and lower myostatin mRNA levels [30,
31]. Although IGF-1 is known for its role in muscle growth,
recently its role in loading-induced muscle hypertrophy has
been questioned [32–34]. Functional overloading inmicewas
shown to induce hypertrophy without a functional IGF-1
receptor [34] and acute resistance exercise in mice did not
change IGF-1 receptor phosphorylation [32], indicating that
hypertrophy can occur in an IGF-1 independent manner.
Effects of Training on LowOxidative Compartment.Also in the
low oxidative compartment, myostatin and MuRF-1 mRNA
levels were significantly different after training (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃
and 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃, resp.), whereas IGF-1Ea, 𝛼𝛼-skeletal actin,
and MAFbx remained unchanged (Figure 3). PT resulted in
a 2.1-fold higher myostatin mRNA content compared to that
in controls (𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃), while myostatin mRNA content
after PET was unchanged. PT also induced a 1.9-fold higher
MuRF-1 mRNA expression compared to that after PET (𝑃𝑃 𝑃𝑃𝑃𝑃𝑃2). Similar to the high oxidative compartment, addi-
tional endurance training, performed by PET, inhibited the
substantial increase inmyostatinmRNAcontent and induced
a decrease in MuRF-1 mRNA content compared to PT. Since
phospho-S6 protein levels remained unchanged after train-
ing, the higher myostatin levels after PT were unlikely
to inhibit Akt/mTOR signalling but rather seem to have
increased the rate of protein degradation which is reflected
by higher MuRF-1 mRNA levels. Note, that as we assessed
mRNA levels of the E3 ubiquitin ligases, it remains uncertain
whether their protein levels were also increased after PT.
Although the elevated catabolic status within the muscle of
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Figure 3: Effects of training on gene expression of regulatory factors of muscle protein synthesis and degradation and downstream targets. (a)
and (b) show typical examples of cross-sections from the proximal (i.e., high oxidative compartment) and distal regions (i.e., low oxidative
compartment), respectively, of rat medial gastrocnemius muscle, which were stained for succinate dehydrogenase activity. These images
demonstrate that the proximal region predominantly consists of high oxidative fibreswhereas the distal regionmainly consists of low oxidative
fibres. RNA was extracted from these regions. Effects of peak power training alone (PT) and peak power training in combination with
endurance training (PET) are shown on the gene expression of IGF-1Ea (c), myostatin (d), 𝛼𝛼-skeletal actin (e), MuRF-1 (f), and MAFbx
(g) in the high (black bars) and low (white bars) oxidative compartments of GM. mRNA expression is relative to 18S rRNA. All values are
mean ± SE. Bars indicate 1000𝜇𝜇m. ∗= significant difference between the groups (𝑃𝑃 𝑃 𝑃𝑃𝑃5). IGF-1Ea: insulin-like growth factor 1Ea, MAFbx:
muscle atrophy F-box, MuRF-1: muscle ring finger 1.
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Figure 4: Effects of training on the phospho-S6 levels. Peak
power training alone (PT) and peak power training in combination
with endurance training (PET) did not affect phospho-S6 protein
content in the high (black bars) and low (white bars) oxidative
compartments of rat medial gastrocnemius muscle. Protein content
was normalized to actin levels. All values are mean ± SE.
the PT group was not accompanied by a decrease in FCSA,
and PT even resulted in a 10% higher 𝐹𝐹max, the substantial
increase in myostatin mRNA after PT in the low oxidative
compartment was unexpected. However, in agreement with
our observations, elevated myostatin mRNA, protein and
serum levels were observed after 3, 6, and 12 weeks of
resistance training in humans which was also accompanied
with an increase in maximal force [35, 36]. In addition,
high myostatin levels may not always be associated with
smaller FCSA. Paradoxically, myostatin is more abundantly
expressed in fast muscles (i.e., m. Extensor digitorum longus)
consisting predominantly of large type IIX and IIB fibres
compared to slow muscles (i.e., m. Soleus) [11, 37]. Fur-
thermore, the percentage type IIB fibres of a muscle were
shown to be positively related (𝑟𝑟 𝑟 𝑟𝑟𝑟𝑟𝑟) to its myostatin
mRNA content [38], suggesting that althoughmyostatin may
be a negative regulator of muscle fibre size in general, the
magnitude of its impact seems fibre type specific.
4. Conclusions
We investigatedwhether by using task-specific recruitment of
GM, additional endurance training would not interfere with
the peak power training induced adaptive responses. While
the increase in maximal running velocity was similar in both
training groups, 𝐹𝐹max of GM was only increased after peak
power training alone and not after concurrent peak power
and endurance training. In addition, in both, the high and
low oxidative compartments, additional endurance training
performed by PET induced different expression levels of
genes involved in protein synthesis and degradation than
PT, suggesting an interaction between the training response
of peak power and endurance training. Thus, even by using
task-specific recruitment of the compartmentalized rat GM,
additional endurance training interfered with the adaptive
response of peak power training and attenuated the increase
in 𝐹𝐹max after peak power training. Further research is needed
to investigate how these two training types can best be
combined to prevent interference at the cellular level and
improve the size and maximal force of the entire muscle.
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